GP40141
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GP40141, covering 2024-07-11 to 2024-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia [Phase 3]